BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7747552)

  • 1. Treatment of generalized bullous pemphigoid with topical corticosteroids.
    Spuls PI; Brakman M; Westerhof W; Bos JD
    Acta Derm Venereol; 1995 Jan; 75(1):89. PubMed ID: 7747552
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
    Muramatsu T; Iida T; Shirai T
    J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pemphigoid gestationis: treatment by topical class I corticosteroid].
    Valeyrie L; Lebrun-Vignes B; Bodak N; Grossin M; Descamps V; Crickx B; Bélaïch S
    Ann Dermatol Venereol; 2001 May; 128(5):638-40. PubMed ID: 11427799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bullous pemphigoid with dapsone: retrospective study of thirty-six cases.
    Bouscarat F; Chosidow O; Picard-Dahan C; Sakiz V; Crickx B; Prost C; Roujeau JC; Revuz J; Belaich S
    J Am Acad Dermatol; 1996 Apr; 34(4):683-4. PubMed ID: 8601662
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
    Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
    [No Abstract]   [Full Text] [Related]  

  • 6. Bullous pemphigoid treated by topical corticosteroids.
    Paquet P; Richelle M; Lapiere CM
    Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid.
    Claudy A
    Clin Dermatol; 2001; 19(6):778-80. PubMed ID: 11705688
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical corticosteroids and bullous pemphigoid.
    Hull CM; McKenna JK; Zone JJ
    Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of bullous pemphigoid with topical clobetasol propionate.
    Westerhof W
    J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative efficacy of glucocorticoid preparations in the local therapy of inflammatory degenerative diseases of the locomotor apparatus].
    Bel'kov AV; Vavulov IuA
    Voen Med Zh; 2001 Sep; 322(9):58-61. PubMed ID: 11668794
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
    Zimmermann R; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous pemphigoid--management of a patient with oral and skin lesions.
    Ali TB; Zain RB; Adam BA
    Singapore Dent J; 1994 Jan; 19(1):18-21. PubMed ID: 9582679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric disorders due to clobetasol propionate misuse].
    Law Ping Man L; Poreaux C; Cuny JF; Javot L; Petitpain N; Barbaud A; Schmutz JL
    Therapie; 2013; 68(3):179-81. PubMed ID: 23886466
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
    Schmied C; Saurat JH
    Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diprosone (betamethasone dipropionate) Creame 0-05%. Review and report of a multicentre study.
    Chambers WB; Cash WS; Marinaccio A
    J Int Med Res; 1976; 4(3 Suppl):1-26. PubMed ID: 799993
    [No Abstract]   [Full Text] [Related]  

  • 18. Bullous pemphigoid in adolescence, a rare demographic.
    Brown H; Lamrock E; Jenkins D
    Australas J Dermatol; 2021 Feb; 62(1):e95-e97. PubMed ID: 32935855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
    Zackheim HS; Kashani-Sabet M; Amin S
    Arch Dermatol; 1998 Aug; 134(8):949-54. PubMed ID: 9722724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.